Sunday, August 30, 2015 1:08:53 PM
On August 3 I sent a note to Dr. Alexander:
Dr. Alexander,
I very much appreciate what you and the Cellceutix team are doing to advance the pipeline. i am a long term investor with approximately xxxk shares.
A couple of Brilacidin oral rinse questions:
(1) It looks like enrollment opened at the first two sites about 9 weeks ago. Do you know about how many patients have been enrolled from these first two sites and if any have completed the 7 week treatment regimen?
(2) Reviewing the inclusion and exclusion criteria for the B-OM trial, can you give me an idea of about how many patients are likely eligible at each center over a 'typical' month? I am trying to get a read on how easy/difficult it is to find patients for what appears relatively stringent trial criteria.
Thank you very much.
And the appropriate somewhat vague response:
So all I really know is that as of the 1st week of August, more than a couple patients were enrolled. It's interesting that we both used the term 'stringent' to describe trial inclusion criteria and you outlined the reasoning really well. I think this particular population has 90%+ incidence of severe (Grade 3,4) oral mucositis but my sources are somewhat conflicting.
I hope they can enroll one patient every week at each site but this might be overly optimistic. No basis for my opinion but I was thinking/hoping 1 or 2 a month at each location (your 2nd scenario). Perhaps Leo will give us a better read in the coming weeks.
Thanks again. Looking forward to your ongoing thoughts/comments.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM